Clover Health Investments Stock Earnings Reports

Clover Health reported strong first quarter 2026 results, combining rapid membership growth with GAAP profitability. Membership increased ~51% YoY to ~156k Medicare Advantage members, driving revenue of $749M (up 62% YoY). The company generated $27M GAAP net income and $40M adjusted EBITDA, with consolidated gross profit of $160M and an insurance benefit expense ratio of 86.5%. Key operational drivers include expanding engagement with Clover Assistant (over one-third of members engaged), record home-care enrollments (Clover Care Services), improved retention from AEP, and continued SG&A leverage (adjusted SG&A $119M, ~16% of revenue). Clover emphasized its differentiated wide‑network PPO model that retains full economics (limited delegation), a data/AI advantage enabled by early access to CMS-aligned networks, and cohort-driven lifetime value that should improve margins as newer members mature. Counterpart Health is positioned as a productized offering to sell its care tools to other plans and providers, with initial traction outside core markets. Financial position is solid: $418M cash & investments, no debt, and $108M cash from operations in the quarter. Management reiterated it expects to meet or exceed full-year 2026 outlook but will revisit guidance after Q2 and is taking a disciplined stance as newer cohorts mature. Near-term monitoring focuses on outpatient utilization, Part D trends, and pacing of Counterpart investments. Risks called out include normal cohort maturation uncertainty and potential variability in outpatient and Part D costs.